cardiac mdct for determining aetiology of pulmonary hypertension
DESCRIPTION
TRANSCRIPT
![Page 1: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/1.jpg)
Incremental Value of Cardiac MDCT over Trans-thoracic and Trans-esophageal Echocardiography for Determining Underlying Cause of Pulmonary HTN
Muhammad Ayub, FCPSDiplomate CBNC; Diplomate CBCCT
Department of Cardiovascular ImagingPunjab Institute of Cardiology Lahore, Pakistan
![Page 2: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/2.jpg)
Established pulmonary arterial hypertension (PAH) carries bad prognosis
Early detection of underlying cause of PAH may be of great prognostic and therapeutic importance
Background
![Page 3: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/3.jpg)
Trans-thoracic and trans-esophageal echocardiographies are great tools for diagnosis of cardiac causes of PAH, but have their own limitations
Cardiac MDCT, owing to it high spatial resolution, can provide excellent information about cardiac chambers, shunts, pulmonary vessels and lung parencyma.
Background
![Page 4: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/4.jpg)
To determine incremental diagnostic value of cardiac MDCT over trans-thoracic and trans-esophageal echocardiography in determining secondary cause of PAH
Objectives
![Page 5: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/5.jpg)
15
45
MalesFemales
Patients
![Page 6: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/6.jpg)
Sixty patients (15 m, 45f) aged 32+11 with severe pulmonary arterial hypertension (mean 66.9+11.59 mmHg) without any obvious cause for PAH on trans-thoracic and trans- esophageal echocardiography were selected for the study.
Patients
![Page 7: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/7.jpg)
All patients underwent gated cardiac MDCT on GE Lightspeed VCT after intravenous contrast at a rate of 5-7ml per second
Large field of view was used during data acquisition to include pulmonary vessels and lungs in the field
Scanning was done using 100-120 KV and 500-750 mAs according to patient’s height and weight
Methods
![Page 8: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/8.jpg)
Retrospective ECG gating was used for acquisition and multi-phase data were reconstructed for evaluation of pulmonary vessels and for presence or absence any cardiac or extra-cardiac shunts
Additionally, lung parenchyma were also analyzed for presence or absence any lung pathology.
Methods
![Page 9: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/9.jpg)
Frequency of abnormalities found on MDCT in patients with pulmonary hypertension without any discernable cause on TTE or TEE
PDA ASD PE Lung Disease0
1
2
3
4
5
6
7 6
3
5
7
![Page 10: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/10.jpg)
Cardiac MDCT has incremental diagnostic value over trans-thoracic and trans-esophageal echocardiography for identifying the underlying cause of PAH.
Conclusions
![Page 11: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/11.jpg)
Examples
PDA VR PDA MPR
![Page 12: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/12.jpg)
Examples
SV ASD PAPVD
![Page 13: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/13.jpg)
Examples
Secundum ASD In situ Clot
![Page 14: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/14.jpg)
Examples
VSD VR
![Page 15: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/15.jpg)
Examples
Pulmonary Embolism Pulmonary Embolism
![Page 16: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/16.jpg)
Examples
Lung Disease Lung Disease
![Page 17: Cardiac mdct for determining aetiology of pulmonary hypertension](https://reader033.vdocuments.net/reader033/viewer/2022061214/547deaffb4af9fea158b54d3/html5/thumbnails/17.jpg)
Thank you for listening